Bibliographic Details
| Title: |
Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors. |
| Authors: |
Stepan AF; Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States. Antonia.Stepan@pfizer.com, Karki K, McDonald WS, Dorff PH, Dutra JK, Dirico KJ, Won A, Subramanyam C, Efremov IV, O'Donnell CJ, Nolan CE, Becker SL, Pustilnik LR, Sneed B, Sun H, Lu Y, Robshaw AE, Riddell D, O'Sullivan TJ, Sibley E, Capetta S, Atchison K, Hallgren AJ, Miller E, Wood A, Obach RS |
| Source: |
Journal of medicinal chemistry [J Med Chem] 2011 Nov 24; Vol. 54 (22), pp. 7772-83. Date of Electronic Publication: 2011 Oct 26. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
